CIK 0001517022 · Large accelerated filer
Akebia Therapeutics, Inc.
Sign in to watch- Ticker
- AKBA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 208756903
- Phone
- 617-871-2098
- Business address
- 180 THIRD AVENUE, FLOOR 2, WALTHAM, MA, 02451
- 4 Grant or award CCO acquired 9,152 shares (grant or award)
- 4 Grant or award SVP, Chief Legal Officer acquired 10,192 shares (grant or award)
- 4 Grant or award SVP, Chief Operating Officer acquired 11,648 shares (grant or award)
- 4 Grant or award CEO and President acquired 39,520 shares (grant or award)
- 4 Grant or award SVP, Chief Medical Officer acquired 10,400 shares (grant or award)
- 4 Open-market sale CEO and President sold 49,990 shares at $3.40 ($169,771)
- 4 Open-market sale CCO sold 6,749 shares at $3.40 ($22,920)
- 4 Open-market sale SVP, Chief Legal Officer sold 14,285 shares at $3.40 ($48,513)
- 4 Open-market sale SVP, Chief Operating Officer sold 14,547 shares at $3.40 ($49,403)
- 4 Open-market sale SVP, Chief Medical Officer sold 7,558 shares at $3.40 ($25,668)
- 4 Grant or award SVP, Chief Accounting Officer acquired 26,000 shares (grant or award)
- 4 Grant or award SVP, CFO and Treasurer acquired 70,000 shares (grant or award)
- S-3ASR Offering Registration Statement
- 10-K Report Annual Report
- 8-K Event Results of operations
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- 8-K Event Material agreement
- SC 13G/A Stake Amended Statement of Ownership
Page 19 of 45 · 886 filings